title: Acute treatment of ST-segment-elevation myocardial infarction: is there a role for the cardiac surgeon?
abstract: BACKGROUND
  Several attempts from single institutions to treat acute myocardial infarctions with bypass surgery never reached widespread acceptance in the cardiology and surgical community. Owing to a variety of new surgical techniques, this old dogma has to be reconsidered under the light of patient-adjusted optimal treatment algorithms.
  
  
  METHODS
  Between August 2002 and August 2007, 112 patients, mean age of 66 years (range, 41 to 85 years), underwent emergency coronary artery bypass grafting (untreatable or rejected by the referring cardiologists within 48 hours after onset of symptoms). Thirty-seven patients (33%) exhibited cardiogenic shock, and 18 (16%) had prior cardiopulmonary resuscitation. Preoperative support by intraaortic balloon pump was initiated in only 10%, and 65% had left main stem stenosis.
  
  
  RESULTS
  All patients showed a significant elevation of cardiac markers (creatine kinase-MB) and ST-segment elevation. The mean number of grafts was 2.4 (range, 1 to 4). The cardiopulmonary bypass time ranged from 48 to 261 minutes. Intraaortic balloon pump for weaning from extracorporeal circulation was used in 42 patients (38%); 3 patients needed extracorporeal membrane oxygenation support. Postoperative complications included rethoracotomy for bleeding in 4% and stroke in 2%. Thirty-day mortality was 20% in the whole group, 30% in the group with cardiogenic shock, and 15% in those without hemodynamic deterioration (p = 0.044). The multivariate analysis revealed the preoperative need for catecholamines as the only risk factor for 30-day mortality (odds ratio, 6.4; 95% confidence interval, 2 to 21; p = 0.002).
  
  
  CONCLUSIONS
  Emergency coronary artery bypass grafting in patients with acute myocardial infarction can be performed with acceptable results, especially in those without cardiogenic shock. Therefore, operative revascularization should not be considered only as a rescue therapy.
authors.affiliation: Division of Cardiac, Thoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany. hagl.christian@mh-hannover.de
authors.forename: Christian
authors.initials: C
authors.lastname: Hagl
authors.forename: Nawid
authors.initials: N
authors.lastname: Khaladj
authors.forename: Sven
authors.initials: S
authors.lastname: Peterss
authors.forename: Andreas
authors.initials: A
authors.lastname: Martens
authors.forename: Ingo
authors.initials: I
authors.lastname: Kutschka
authors.forename: Heidi
authors.initials: H
authors.lastname: Goerler
authors.forename: Malakh
authors.initials: M
authors.lastname: Shrestha
authors.forename: Axel
authors.initials: A
authors.lastname: Haverich
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002315:Cardiopulmonary Bypass / Q000379:methods; D001026:Coronary Artery Bypass / Q000379:methods*; D004562:Electrocardiography; D005112:Extracorporeal Circulation / Q000379:methods*; D015199:Extracorporeal Membrane Oxygenation / Q000379:methods; D005260:Female; D005500:Follow-Up Studies; D005858:Germany / Q000453:epidemiology; D006801:Humans; D007423:Intra-Aortic Balloon Pumping / Q000379:methods*; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000401:mortality / Q000628:therapy*; D010819:Physician's Role; D011183:Postoperative Complications / Q000517:prevention & control; D011300:Preoperative Care / Q000379:methods*; D012189:Retrospective Studies; D015996:Survival Rate / Q000639:trends; D016896:Treatment Outcome